Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers’ first choice for patients with Type 2 diabetes.
Related Posts
Trump vows to revoke Harvard’s tax-exempt status: ‘It’s what they deserve!’
Trump has sought to extract concessions and changes from Harvard and other schools by threatening to withhold federal research grants.
Republican senators join Dems on bill to exempt small businesses from Trump’s Canada tariffs
Trump recently said he will impose a 35% tariff on Canada, the latest salvo in his on-again, off-again trade war with the U.S. ally and […]
Bluesky’s growing pains
As Bluesky evolves into an increasingly relevant platform, it faces both predictable and surprising bumps in the road.